113 related articles for article (PubMed ID: 21691200)
21. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
22. Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.
Ingimarsson JP; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
Scand J Urol Nephrol; 2011 Nov; 45(5):306-11. PubMed ID: 21619417
[TBL] [Abstract][Full Text] [Related]
23. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
24. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
25. Expression of S-100 protein in renal cell neoplasms.
Lin F; Yang W; Betten M; Teh BT; Yang XJ;
Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
[TBL] [Abstract][Full Text] [Related]
26. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
28. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
[TBL] [Abstract][Full Text] [Related]
29. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
30. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression.
Kohya N; Kitajima Y; Jiao W; Miyazaki K
Int J Cancer; 2003 Mar; 104(1):44-53. PubMed ID: 12532418
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
[TBL] [Abstract][Full Text] [Related]
32. Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.
Maelandsmo GM; Flørenes VA; Nguyen MT; Flatmark K; Davidson B
Tumour Biol; 2009; 30(1):15-25. PubMed ID: 19194111
[TBL] [Abstract][Full Text] [Related]
33. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
34. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
[TBL] [Abstract][Full Text] [Related]
35. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.
Eyzaguirre EJ; Miettinen M; Norris BA; Gatalica Z
Mod Pathol; 1999 Oct; 12(10):979-83. PubMed ID: 10530564
[TBL] [Abstract][Full Text] [Related]
36. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
37. Parvalbumin is constantly expressed in chromophobe renal carcinoma.
Martignoni G; Pea M; Chilosi M; Brunelli M; Scarpa A; Colato C; Tardanico R; Zamboni G; Bonetti F
Mod Pathol; 2001 Aug; 14(8):760-7. PubMed ID: 11504835
[TBL] [Abstract][Full Text] [Related]
38. Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression.
Kikuchi N; Horiuchi A; Osada R; Imai T; Wang C; Chen X; Konishi I
Cancer Sci; 2006 Oct; 97(10):1061-9. PubMed ID: 16984379
[TBL] [Abstract][Full Text] [Related]
39. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study.
Steffens S; Janssen M; Roos FC; Becker F; Schumacher S; Seidel C; Wegener G; Thüroff JW; Hofmann R; Stöckle M; Siemer S; Schrader M; Hartmann A; Kuczyk MA; Junker K; Schrader AJ
Eur J Cancer; 2012 Oct; 48(15):2347-52. PubMed ID: 22698386
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
